{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:22:28Z","timestamp":1698758548433},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> Fluid resuscitation is a frequent intervention in intensive care. Colloids are widely used, but recent data suggest harm by some of these solutions. This calls for more clinical studies on this matter, but the current preferences for colloid use in Scandinavian intensive care units (ICUs) are unknown.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> In March\u2013May 2007, 120 Scandinavian ICUs were invited to answer a web\u2010based survey consisting of 18 questions on types of colloids, indications, contraindications and rationale of use.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Seventy\u2010three ICUs, of which 31 were university hospital units, answered the questionnaire. Most ICUs used both synthetic and natural colloids, and hydroxyethyl starch (HES) 130\/0.4 was the preferred colloid in 59 units. Eleven ICUs had protocols for colloid use. The most frequent indication was second\u2010line fluid for hypovolaemia, but one in three ICUs used colloids as first\u2010line fluid. Thirty\u2010five ICUs had contraindications, which were mainly for the use of synthetic colloids (acute renal failure 25 units, bleeding 15 units). Most units based the use of colloids on theoretical knowledge and tradition. Sixty\u2010five and 54 ICUs were ready to change colloid use based on data from randomised trials of ICU patients showing changes in mortality or renal function, respectively.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Most Scandinavian ICUs use both synthetic and natural colloids, but HES 130\/0.4 is by far the preferred colloid. Few units have protocols for colloid use, but most use them for hypovolaemia, and the majority have no contraindications. Most ICUs are ready to change colloid use if randomised trials in ICU patients show changes in mortality or renal function.<\/jats:p>","DOI":"10.1111\/j.1399-6576.2008.01690.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:52:01Z","timestamp":1281624721000},"page":"750-758","source":"Crossref","is-referenced-by-count":27,"title":["Preferences for colloid use in Scandinavian intensive care units"],"prefix":"10.1111","volume":"52","author":[{"name":"The FLUIDS study investigators for the Scandinavian Critical Care Trials Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-909ST"},{"key":"e_1_2_6_3_2","first-page":"235","article-title":"Human albumin administration in critically ill patients","volume":"317","author":"Cochrane Injuries Group Albumin Reviewers.","year":"1998","journal-title":"systematic review of randomised controlled trials"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040232"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067514"},{"key":"e_1_2_6_6_2","first-page":"911","article-title":"Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis","volume":"357","author":"Schortgen F","year":"2001","journal-title":"a multicentre randomised study"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070716"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2005.00619.x"},{"key":"e_1_2_6_9_2","first-page":"1163","article-title":"Colloids decrease clot propagation and strength","volume":"49","author":"Nielsen VG.","year":"2005","journal-title":"role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2003.00129.x"},{"key":"e_1_2_6_11_2","first-page":"2659","article-title":"Swedish practice routines for fluid therapy are considerably changing","volume":"102","author":"Haljamae H.","year":"2005","journal-title":"L\u00e4kartidningen"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael333"},{"key":"e_1_2_6_13_2","first-page":"2222","article-title":"Preferred plasma volume expanders for critically ill patients","volume":"30","author":"Schortgen F","year":"2004","journal-title":"results of an international survey"},{"key":"e_1_2_6_14_2","first-page":"929","article-title":"Volume\u2010targeted therapy of increased intracranial pressure","volume":"46","author":"Gr\u00e4nde PO","year":"2002","journal-title":"the Lund concept unifies surgical and non-surgical treatments"},{"key":"e_1_2_6_15_2","first-page":"655","article-title":"The effects of hydroxyethyl starch solution in critically ill patients","volume":"72","author":"Palumbo D","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_6_16_2","first-page":"S213","article-title":"Hydroxyethyl starch and Ringer's lactate for fluid resuscitation in patients with severe sepsis \u2013 results from the VISEP study","volume":"32","author":"Reinhart K","year":"2006","journal-title":"Intensive Care Med"},{"key":"e_1_2_6_17_2","first-page":"28","article-title":"Volume therapy in the critically ill","volume":"24","author":"Boldt J","year":"1998","journal-title":"is there a difference?"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-006-1122-4"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05720-8"},{"key":"e_1_2_6_20_2","first-page":"19","article-title":"Use of albumin in intensive care units in the United Kingdom","volume":"3","author":"Brown JM","year":"2001","journal-title":"Crit Care Resusc"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.2008.01690.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.2008.01690.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T01:33:19Z","timestamp":1696901599000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.2008.01690.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1399-6576.2008.01690.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.2008.01690.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}